Future research in HLA and toxicology aims to expand our understanding of the genetic basis of individual variability in toxic responses. Advances in genomic technologies and large-scale population studies will likely identify new HLA-associated toxicological risks. This knowledge will be crucial for developing improved screening tools and interventions that minimize adverse reactions and maximize the efficacy of therapeutic interventions.
